Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7601 to 7650 of 8907 results

  1. Endoscopic dacryocystorhinostomy (IPG113)

    We have moved interventional procedures guidance 113 to become HealthTech guidance 68. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Lung volume reduction surgery for advanced emphysema (IPG114)

    We have moved interventional procedures guidance 114 to become HealthTech guidance 69. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. Complete cytoreduction and heated intraperitoneal intraoperative chemotherapy (Sugarbaker technique) for peritoneal carcinomatosis (IPG116)

    This guidance has been updated and replaced by NICE interventional procedure guidance 331.

    Withdrawn guidance

  4. High-intensity focused ultrasound for prostate cancer (IPG118)

    We have moved interventional procedures guidance 118 to become HealthTech guidance 70. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Cryotherapy for recurrent prostate cancer (IPG119)

    We have moved interventional procedures guidance 119 to become HealthTech guidance 71. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  6. Mini-incision surgery for total knee replacement (IPG117)

    This guidance has been updated and replaced by NICE HealthTech guidance 220.

    Withdrawn guidance

  7. Percutaneous vertebroplasty (IPG12)

    We have moved interventional procedures guidance 12 to become HealthTech guidance 3. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. Potassium-titanyl-phosphate (KTP) laser vaporisation of the prostate for benign prostatic obstruction (IPG120)

    Summary --> This guidance has been updated and replaced by NICE guidance CG97.

    Withdrawn guidance

  9. Microwave ablation for atrial fibrillation in association with other cardiac surgery (IPG122)

    We have moved interventional procedures guidance 122 to become HealthTech guidance 73. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery (IPG121)

    We have moved interventional procedures guidance 121 to become HealthTech guidance 72. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Cryoablation for atrial fibrillation in association with other cardiac surgery (IPG123)

    We have moved interventional procedures guidance 123 to become HealthTech guidance 74. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Radiofrequency ablation of the soft palate for snoring (IPG124)

    Interventional procedures, IPG124 - Issued: May 2005 --> This guidance has been replaced by NICE interventional procedure guidance 476.

    Withdrawn guidance

  13. Endovascular stent–graft placement in thoracic aortic aneurysms and dissections (IPG127)

    We have moved interventional procedures guidance 127 to become HealthTech guidance 76. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Posterior infracoccygeal sacropexy for vaginal vault prolapse (IPG125)

    This guidance has been updated and replaced by NICE interventional procedure guidance 281.

    Withdrawn guidance

  15. Leukapheresis for inflammatory bowel disease (IPG126)

    We have moved interventional procedures guidance 126 to become HealthTech guidance 75. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  16. Totally endoscopic robotically assisted coronary artery bypass grafting (IPG128)

    Interventional procedures, IPG128 - Issued: June 2005 --> We have moved interventional procedures guidance 128 to become HealthTech guidance 77. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  17. Interstitial laser therapy for fibroadenomas of the breast (IPG131)

    We have moved interventional procedures guidance 131 to become HealthTech guidance 80. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  18. Pancreatic islet cell transplantation (IPG13)

    NICE's guidance on pancreatic islet cell transplantation has now been replaced. Please see NICE's HealthTech guidance 165 for the full guidance on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus and to NICE's HealthTech guidance 175 to view the full guidance on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy issued to the NHS in England, Wales, Scotland and Northern Ireland.

    Withdrawn guidance

  19. Computed tomographic colonography (virtual colonoscopy) (IPG129)

    We have moved interventional procedures guidance 129 to become HealthTech guidance 78. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  20. Collagen injection for vocal cord augmentation (IPG130)

    We have moved interventional procedures guidance 130 to become HealthTech guidance 79. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  21. Low dose rate brachytherapy for localised prostate cancer (IPG132)

    We have moved interventional procedures guidance 132 to become HealthTech guidance 81. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  22. Insertion of extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women (IPG133)

    This guidance has been updated and replaced by NICE interventional procedures guidance 576.

    Withdrawn guidance

  23. Laparoscopic liver resection (IPG135)

    We have moved interventional procedures guidance 135 to become HealthTech guidance 83. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  24. Extracorporeal shock wave therapy for refractory tendinopathies (plantar fasciitis and tennis elbow) (IPG139)

    This guidance has been updated and replaced by NICE HealthTech guidance 201.

    Withdrawn guidance

  25. Photodynamic therapy for localised inoperable endobronchial cancer (IPG137)

    We have moved interventional procedures guidance 137 to become HealthTech guidance 85. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  26. Photodynamic therapy for bile duct cancer (IPG134)

    We have moved interventional procedures guidance 134 to become HealthTech guidance 82. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  27. Laparoscopic nephrectomy (including nephroureterectomy) (IPG136)

    We have moved interventional procedures guidance 136 to become HealthTech guidance 84. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  28. Transurethral electrovaporisation of the prostate (IPG14)

    Interventional procedures, IPG14 - Issued: October 2003 --> We have moved interventional procedures guidance 14 to become HealthTech guidance 4. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  29. Intramural urethral bulking procedures for stress urinary incontinence in women (IPG138)

    We have moved interventional procedures guidance 138 to become HealthTech guidance 86. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  30. Metatarsophalangeal joint replacement of the hallux (IPG140)

    We have moved interventional procedures guidance 140 to become HealthTech guidance 87. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  31. Cryotherapy for malignant endobronchial obstruction (IPG142)

    We have moved interventional procedures guidance 142 to become HealthTech guidance 89. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  32. Direct C1 lateral mass screw for cervical spine stabilisation (IPG146)

    We have moved interventional procedures guidance 146 to become HealthTech guidance 92. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  33. Intraoperative blood cell salvage in obstetrics (IPG144)

    We have moved interventional procedures guidance 144 to become HealthTech guidance 90. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  34. Automated percutaneous mechanical lumbar discectomy (IPG141)

    Interventional procedures, IPG141 - Issued: November 2005 --> We have moved interventional procedures guidance 141 to become HealthTech guidance 88. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  35. Prosthetic intervertebral disc replacement in the cervical spine (IPG143)

    This guidance has been updated and replaced by NICE HealthTech guidance 217.

    Withdrawn guidance

  36. Cryotherapy as a primary treatment for prostate cancer (IPG145)

    We have moved interventional procedures guidance 145 to become HealthTech guidance 91. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  37. Endoscopic axillary lymph node retrieval for breast cancer (IPG147)

    We have moved interventional procedures guidance 147 to become HealthTech guidance 93. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  38. Retrobulbar irradiation for thyroid eye disease (IPG148)

    We have moved interventional procedures guidance 148 to become HealthTech guidance 94. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  39. Transurethral radiofrequency needle ablation of the prostate (IPG15)

    This guidance has been updated and replaced by NICE guideline CG97.

    Withdrawn guidance

  40. KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment (HTE10)

    We have moved health technology evaluation 10 to become HealthTech guidance 694. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  41. Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (HTE1)

    We have moved HTE1 to become 'antimicrobial resistance guidance'. This is to better reflect what the purpose of this product is and to help you find relevant content more quickly. The guidance itself has not changed. See antimicrobial resistance guidance 1 on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.

    Withdrawn guidance

  42. Artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12)

    We have moved health technology evaluation 12 to become HealthTech guidance 696. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  43. Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)

    We have moved health technology evaluation 11 to become HealthTech guidance 695. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  44. Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment (HTE15)

    We have moved health technology evaluation 15 to become HealthTech guidance 701. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  45. Digital technologies for managing non-specific low back pain: early value assessment (HTE16)

    We have moved health technology evaluation 16 to become HealthTech guidance 712. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  46. Virtual ward platform technologies for acute respiratory infections: early value assessment (HTE13)

    We have moved health technology evaluation 13 to become HealthTech guidance 697. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  47. Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)

    We have moved health technology evaluation 14 to become HealthTech guidance 700. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  48. Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTE17)

    We have moved Health technology evaluation 17 to become HealthTech guidance 713. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  49. Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)

    We have moved Health technology evaluation 18 to become HealthTech guidance 718. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  50. Digital technologies to support self-management of COPD: early value assessment (HTE19)

    We have moved Health technology evaluation 19 to become HealthTech guidance 736. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance